This notion is supported by our analyses of patients’ bone marrow aspirates using an ex-vivo cytotoxicity test allowing direct comparison of the toxic effect of CuET on MM (CD319+/CD138+ positive) vs normal plasma cells. This evidence concerns the gene SDC1 and Miyoshi myopathy.